| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |